A Prospective Study of EUS Guided Celiac Block

The purpose of this prospective study is to measure the clinical effectiveness of EUS-guided CB in subjects, 50 who have chronic pancreatitis and 50 who have pancreatic cancer, that are already undergoing celiac block for clinical reasons.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Pancreatitis Chronic Disease Digestive System Diseases Digestive System Neoplasms Disease Attributes Endocrine Gland Neoplasms Endocrine System Diseases Neoplasms Neoplasms by Site Pancreatic Cancer Pancreatic Diseases Pancreatic Neoplasms Pancreatitis Pancreatitis, Chronic Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Clarian Health: Indiana University Hospital

Indianapolis, Indiana, 46202, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with chronic abdominal pain from documented chronic pancreatitis or pancreatic cancer or other visceral malignancy that are undergoing EUS-guided CB (for purposes other than this study) will be eligible to participate in this study.
Patients with chronic pancreatitis and pancreatic cancer must have documented disease by CT, ERCP, or EUS.
No evidence of dementia or altered mental status that would prohibit the giving and understanding of informed consent, and no evidence of psychiatric risk that would preclude adequate compliance with this protocol.
Patient must provide signed written informed consent

Exclusion criteria

Patients that have had a previous celiac plexus block are eligible for this study

Treatment and study plan

Triamcinolone

Drug

80mg of triamcinolone injected into the celiac ganglion during the EUS-CB

Other names: Kenalog 80mg

98% dehydrated alcohol

Drug

10ml of 98% dehydrated alcohol injected into the celiac ganglion during the EUS-CB

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Registry information

Official study title

A Prospective Study of Endoscopic Ultrasound-guided Celiac (CB) Effectiveness

Important dates

Study start: 2002
Primary completion: 2012
Study completion: 2012
First posted: Dec 31, 2007
Registry last updated: Sep 5, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed